FORM OF REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • June 6th, 2022 • Yumanity Therapeutics, Inc. • Pharmaceutical preparations • Delaware
THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of June [ ], 2022, by and among Yumanity Therapeutics, Inc., a Delaware corporation (the “Company”), and the purchasers set forth on Schedule 1 hereto (each, a “Purchaser”, and collectively, the “Purchasers”), and shall become effective as of the Closing (as defined in the Purchase Agreement, defined below).
FORM OF COMPANY SHAREHOLDER SUPPORT AGREEMENTCompany Shareholder Support Agreement • June 6th, 2022 • Yumanity Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This SUPPORT AGREEMENT (this “Agreement”), dated as of [•], 2022, is by and between YUMANITY THERAPEUTICS, INC., a Delaware corporation (“Yumanity”), KINETA, INC. a Washington corporation (the “Company”) and the undersigned holder (the “Shareholder”) of securities of the Company.
FORM OF YUMANITY THERAPEUTICS, INC. STOCKHOLDER SUPPORT AGREEMENTStockholder Support Agreement • June 6th, 2022 • Yumanity Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This SUPPORT AGREEMENT (this “Agreement”), dated as of [•], 2022, is by and between YUMANITY THERAPEUTICS, INC., a Delaware corporation (“Yumanity”), KINETA, INC. a Washington corporation (the “Company”) and the undersigned holder (the “Stockholder”) of securities of Yumanity.
FORM OF SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 6th, 2022 • Yumanity Therapeutics, Inc. • Pharmaceutical preparations • Delaware
THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of June [ ], 2022 by and among Yumanity Therapeutics, Inc., a Delaware corporation (the “Company”), and the purchasers identified on Schedule 1 hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”). Capitalized terms used herein but not otherwise defined shall have the meanings given to them in Section 1.5.
AGREEMENT AND PLAN OF MERGER BY AND AMONG YUMANITY THERAPEUTICS, INC., YACHT MERGER SUB, INC., and KINETA, INC. Dated as of June 5, 2022Merger Agreement • June 6th, 2022 • Yumanity Therapeutics, Inc. • Pharmaceutical preparations • Delaware
THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”) is made and entered into as of June 5, 2022, by and among YUMANITY THERAPEUTICS, INC., a Delaware corporation (“Yumanity”), YACHT MERGER SUB, INC., a Washington corporation and wholly-owned subsidiary of Yumanity (“Merger Sub”), and KINETA, INC., a Washington corporation (the “Company”). Certain capitalized terms used in this Agreement are defined in Exhibit A.
FORM OF LOCK-UP AGREEMENTLock-Up Agreement • June 6th, 2022 • Yumanity Therapeutics, Inc. • Pharmaceutical preparations • Delaware
ASSET PURCHASE AGREEMENT Dated as of June 5, 2022 between YUMANITY THERAPEUTICS, INC. and JANSSEN PHARMACEUTICA NVAsset Purchase Agreement • June 6th, 2022 • Yumanity Therapeutics, Inc. • Pharmaceutical preparations • New York
This Asset Purchase Agreement (this “Agreement”) dated as of June 5, 2022 is entered into between Janssen Pharmaceutica NV, a company organized under the laws of Belgium (“Buyer”), and Yumanity Therapeutics, Inc., a Delaware corporation (“Seller”). Buyer and Seller are sometimes individually referred to herein as a “Party” and are sometimes collectively referred to herein as the “Parties”. Certain capitalized terms used herein have the meanings ascribed to them in Section 1.1.
